DE60139959D1 - Nukleinsäureadjuvantien - Google Patents

Nukleinsäureadjuvantien

Info

Publication number
DE60139959D1
DE60139959D1 DE60139959T DE60139959T DE60139959D1 DE 60139959 D1 DE60139959 D1 DE 60139959D1 DE 60139959 T DE60139959 T DE 60139959T DE 60139959 T DE60139959 T DE 60139959T DE 60139959 D1 DE60139959 D1 DE 60139959D1
Authority
DE
Germany
Prior art keywords
nucleic acid
molecules
truncated
coding region
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60139959T
Other languages
German (de)
English (en)
Inventor
Joel R Haynes
Joshua E Arrington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Application granted granted Critical
Publication of DE60139959D1 publication Critical patent/DE60139959D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60139959T 2000-11-27 2001-11-26 Nukleinsäureadjuvantien Expired - Lifetime DE60139959D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72431500A 2000-11-27 2000-11-27
PCT/US2001/043151 WO2003004055A2 (en) 2000-11-27 2001-11-26 Nucleic acid adjuvants

Publications (1)

Publication Number Publication Date
DE60139959D1 true DE60139959D1 (de) 2009-10-29

Family

ID=24909936

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139959T Expired - Lifetime DE60139959D1 (de) 2000-11-27 2001-11-26 Nukleinsäureadjuvantien

Country Status (16)

Country Link
EP (1) EP1379273B1 (cg-RX-API-DMAC7.html)
JP (1) JP4221289B2 (cg-RX-API-DMAC7.html)
KR (1) KR20040045391A (cg-RX-API-DMAC7.html)
CN (1) CN1317034C (cg-RX-API-DMAC7.html)
AT (1) ATE442858T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001297988B2 (cg-RX-API-DMAC7.html)
BR (1) BR0115646A (cg-RX-API-DMAC7.html)
CA (1) CA2429708A1 (cg-RX-API-DMAC7.html)
DE (1) DE60139959D1 (cg-RX-API-DMAC7.html)
DK (1) DK1379273T3 (cg-RX-API-DMAC7.html)
ES (1) ES2332261T3 (cg-RX-API-DMAC7.html)
IL (2) IL156041A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03004638A (cg-RX-API-DMAC7.html)
NZ (1) NZ526175A (cg-RX-API-DMAC7.html)
PT (1) PT1379273E (cg-RX-API-DMAC7.html)
WO (1) WO2003004055A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035771A2 (en) 2003-10-10 2005-04-21 Powderject Vaccines, Inc. Nucleic acid constructs
ATE555127T1 (de) 2004-02-11 2012-05-15 Angeletti P Ist Richerche Bio Fusionsproteine des karzinomembryonalen antigens und deren verwendungen
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
US8389686B2 (en) 2008-05-07 2013-03-05 Osaka University Noncovalent collagen crosslinking agent
AU2011302645B2 (en) 2010-09-15 2015-02-26 Applied Molecular Transport, Llc Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
CN103060253A (zh) * 2013-01-24 2013-04-24 麻丽丹 霍乱弧菌ctxAB基因的质粒克隆菌株以及制备方法和应用
EP3139965B1 (en) 2014-05-07 2021-09-29 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
PL3762009T3 (pl) 2018-03-08 2022-09-12 Applied Molecular Transport Inc. Pochodzące z toksyny konstrukty dostarczające do dostarczania doustnego
ES2911075T3 (es) 2018-11-07 2022-05-17 Applied Molecular Transport Inc Constructos de administración para transcitosis y métodos relacionados
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
DE69507321T2 (de) 1994-10-24 1999-07-15 Powderject Research Ltd., Oxford Nadellose spritze
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Also Published As

Publication number Publication date
AU2001297988B2 (en) 2006-10-26
CN1537013A (zh) 2004-10-13
JP4221289B2 (ja) 2009-02-12
ES2332261T3 (es) 2010-02-01
EP1379273A2 (en) 2004-01-14
WO2003004055A2 (en) 2003-01-16
IL156041A0 (en) 2003-12-23
JP2004536107A (ja) 2004-12-02
MXPA03004638A (es) 2004-04-20
PT1379273E (pt) 2009-11-27
NZ526175A (en) 2006-01-27
CN1317034C (zh) 2007-05-23
CA2429708A1 (en) 2003-01-16
IL156041A (en) 2010-05-17
WO2003004055A3 (en) 2003-11-20
DK1379273T3 (da) 2009-11-09
ATE442858T1 (de) 2009-10-15
KR20040045391A (ko) 2004-06-01
EP1379273B1 (en) 2009-09-16
BR0115646A (pt) 2005-12-13

Similar Documents

Publication Publication Date Title
CY1110982T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
BR9906927A (pt) Proteìnas de neisseria meningitidis
ATE357511T1 (de) Dipeptidylpeptidasen
EP1187591A4 (en) MICROBIAL ANTIGENS ASSOCIATED WITH INFLAMMABLE COLON DISEASES (IBD) AND METHODS OF USE THEREOF
BR0010361A (pt) Seq ências genÈmicas de neisseria e uso destas
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
ATE293690T1 (de) Verwendung vom krebs-assoziierten antigen 5t4 zur immuntherapie
ATE442858T1 (de) Nukleinsäureadjuvantien
PT726955E (pt) Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes
ES2152251T3 (es) Variantes del dominio lectina de la selectina.
DK1379550T3 (da) Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser
DK1119630T3 (da) Nukleinsyrekonstruktioner til genetisk immunisering
ATE532861T1 (de) Expressionsvektor
DE60025704D1 (de) Das goodpasture-antigen bindende protein
AU2001248822A1 (en) Gd3-mimetic peptides
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
DE69840326D1 (de) Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
DK0471687T3 (da) Fremgangsmåder og nucleinsyresekvenser til ekspression af cellulosesynthase-operonen
WO2000063385A3 (en) Nucleic acid immunization
DE69836485D1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
WO2000047227A3 (en) Mycobacterium tuberculosis, immunization
DE60229966D1 (de) Diabetesmodell
WO2002083727A3 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition